Novelix Pharmaceuticals Limited (BOM:536565)

Market Cap	987.50M
Revenue (ttm)	849.03M
Net Income (ttm)	9.49M
Shares Out	17.62M
EPS (ttm)	0.76
PE Ratio	73.89
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	14,111
Average Volume	10,661
Open	54.00
Previous Close	52.89
Day's Range	52.52 - 55.45
52-Week Range	24.15 - 70.16
Beta	0.41
RSI	48.11
Earnings Date	Feb 11, 2026

About Novelix Pharmaceuticals

Novelix Pharmaceuticals Limited trades in pharmaceuticals and related products in India. It also trades in shares and securities; retails pharmaceuticals; and offers marketing services. The company was formerly known as Trimurthi Limited and changed its name to Novelix Pharmaceuticals Limited in October 2024. Novelix Pharmaceuticals Limited was incorporated in 1994 and is based in Hyderabad, India.

• Industry: Drugs, Drug Proprietaries, and Druggists' Sundries
• Founded: 1994
• Employees: 8
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 536565

Financial Performance

In 2024, Novelix Pharmaceuticals's revenue was 307.33 million, an increase of 578.26% compared to the previous year's 45.31 million. Earnings were 845,200, an increase of 711.76%.